Expression of PTEN protein in prostatic adenocarcinoma
Authors:
- Thanh Tu DuongTDThanh Tu Duong
- Quoc Thang PhamQPQuoc Thang Pham
- Tan Buu NguyenTNTan Buu Nguyen
- Thanh Thien LyTLThanh Thien Ly
- Ngoc Minh Tam NguyenNNNgoc Minh Tam Nguyen
- Quoc Dat NgoQNQuoc Dat Ngo
Open Access
- 25 December 2024
- journal article
- Published by Hue University of Medicine and Pharmacy in Tạp chí Y Dược Huế
- Vol. 14 (6) , 113
Abstract
Background: PTEN protein is a new biomarker for identifying poor prognosis in prostatic adenocarcinoma. Objective: To evaluate the expression of PTEN protein in prostatic adenocarcinoma and assess the correlation between expression of PTEN protein with other clinicopathological characteristics in prostatic adenocarcinoma. Materials and methods: A descriptive analysis of 121 radical prostatectomy specimens diagnosed with prostatic adenocarcinoma at Binh Dan Hospital from January 2022 to December 2023. Interpret H&E and PTEN immunohistochemistry (IHC) slides. Analyse data and the correlation between clinicopathological and PTEN expression variables. Results: 72.7% of cases showed intact PTEN protein by IHC, while the rates of homogeneous and heterogeneous PTEN loss were 14.1% and 13.2%, respectively. Conclusion: Expression of PTEN protein was significantly associated with the 2019 International Society of Urological Pathology (ISUP) grade groups; however, there was no significant correlation between PTEN expression and other clinicopathological characteristicsKeywords
This publication has 9 references indexed in Scilit:
- Prognostic value of PTEN in de novo diagnosed metastatic prostate cancerAsian Journal of Andrology, 2022
- PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical ProstatectomyJournal of Urology, 2020
- PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohortOncotarget, 2017
- Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHLaboratory Investigation, 2016
- A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate CancerJNCI: Journal of the National Cancer Institute, 2015
- PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancerInternational Journal of Urology, 2014
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancerBritish Journal of Cancer, 2013
- Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancerLaboratory Investigation, 2012
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyCancer, 2012